Cell Culture Media Market

Cell Culture Media Market by Type(Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application(Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User(Pharma, Biotech) - Global Forecast to 2026

Report Code: BT 8052 Mar, 2022, by marketsandmarkets.com

[303 Pages Report] The global cell culture media market is projected to USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026. The growth of this market is majorly driven by the rising R&D spending in pharmaceutical companies, emerging cell culture technologies for cell-based vaccines, increasing demand for monoclonal antibodies, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine. On the other hand, expensive cell biology research products and ethical concerns regarding cell biology research are expected to hinder the growth of this market.

Cell Culture Media Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the Cell Culture Media Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus. Also, the economic and social burden of the pandemic has prompted government bodies globally to increase support for vaccine development and manufacturing, which has led to an increase in the adoption of cell culture media for COVID-19 research. There is an urgent need to better understand the host immune response during disease progression and design appropriate therapeutic interventions for patients with severe disease presentation.

Several pharmaceutical and biotechnology firms have scaled up R&D efforts to develop vaccines and drugs against the virus. Vaccine-related research activities in pharmaceutical and biotechnology companies, research centers, and academic research institutes are considered essential and have been largely unaffected in operations and output. Currently, a number of vaccines or antiviral drugs for COVID-19 have been approved or are under development and manufacturing. As cell culture is an integral part of drug development and manufacturing, this has increased the demand for cell culture products, including cell culture media.

The factors listed below are expected to play a key role in shaping the growth of the cell culture media market:

  • Peripheral blood mononuclear cell (PBMC) specimens of COVID-19 patients are being used to characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection. This is utilized for clinical guidance on anti-inflammatory medication and understanding the molecular mechanisms of the host response to come up with effective therapeutics.
  • Cell-based approaches, primarily using mesenchymal stromal cells (MSCs), have demonstrated a strong safety profile and possible efficacy in acute respiratory distress syndrome (ARDS) patients. Clinical investigations of MSC-based cell therapy approaches began since the onset of the COVID-19 outbreak, coupled with a growing number of academic and industry trials. Cell culture media will play a key role in research pertaining to the novel virus

According to one of the leading bioprocess manufacturers, the impact of the pandemic on supply chains, production, and shipments to customers has been manageable in the overall market. Short and medium-term predictability is extremely limited and has a negligible impact.

Global Cell Culture Media Market Dynamics

DRIVER: Emerging cell culture technologies for cell-based vaccines

In the pharmaceutical industry, cell culture has become a prominent part of vaccine production. The cell culture technology has been used to produce vaccines for rotavirus, polio, smallpox, hepatitis, rubella, and chickenpox. Cell-based flu vaccines have also been approved for use in the US and many European countries.

Earlier, vaccines were manufactured by growing and harvesting viruses in chicken eggs, which was a time-consuming process. On the other hand, cell culture-based vaccine production is a far more efficient method. Its advantages over traditional manufacturing methods include a shortened lead-time and the capability to produce vaccines in larger quantities as per demand. Moreover, cell culture-based vaccines can be stored over a longer period. According to a study published by the CDC in the Journal of Infectious Diseases (June 2020), cell-based vaccines provided greater protection against flu-related hospitalizations than standard-dose egg-based vaccines among Medicare beneficiaries 65 years and older. For the 2020-2021 flu season, all four flu viruses used in Flucelvax Quadrivalent were cell-derived. Consequently, recent years have seen a surge in cell-based vaccines, resulting in efforts by prominent companies to capitalize on the opportunities provided. Seqirus, for example, has been active in this field.

  • In February 2020, Seqirus (a part of CSL Limited) received US FDA approval for AUDENZ, a cell-based Influenza A (H5N1) Monovalent Vaccine for individuals aged six months and older.
  • In January 2019, Seqirus received approval from the European Commission for its new cell-based seasonal influenza vaccine, FLUCELVAX TETRA.
  • In October 2018, Seqirus secured FDA approval for a next-generation cell-based influenza vaccine manufacturing process. This approval has enabled the inclusion of children as young as 6 months. Also, after the FDA approval for its cell-based manufacturing technology, Seqirus went from producing 3 million doses in 2015 to 20 million doses in 2020.

Since there is a surge in demand for cell culture-based vaccines, new techniques for vaccine development are emerging. This has subsequently boosted the demand for cell culture media.

RESTRAINT: Ethical concerns regarding cell biology research

Research in cell biology necessitates the use of animals and humans, as animal and human cells are used in gene therapy studies that involve the recombination of genes and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs, which may harm animals and humans. In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of human embryos. In order to monitor these activities, strict regulations have been formulated by ethical authorities in various countries across the globe. Authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others, have implemented stringent regulations for cell biology research. These ethical concerns and restrictions on the use of cells for research are limiting cell biology research to a great extent in various countries across the globe. This, in turn, is expected to restrict the demand for cell culture products, including cell culture media

OPPORTUNITY: Emerging markets

During the forecast period, emerging countries such as China, India, Brazil, and Mexico are expected to become the focal point for growth in the cell culture media market. Increasing investments in cell biology research and the rising focus of market players on increasing their presence in emerging Asian markets are the major factors responsible for this trend.

Several market players are investing in the development of cell-based research facilities in emerging Asian countries, primarily due to the increasing prevalence of chronic diseases, improvements in infrastructural facilities for research, and favorable legislation for cell-based research. Furthermore, India is an attractive destination for companies operating in the cell culture media market, primarily due to the rising government investments for building high-tech infrastructure for cell-based research, the presence of highly skilled labor, and the low-cost manufacturing advantage. The Indian Department of Pharmaceuticals has prepared a “Pharma Vision 2020” document for making India a leading destination for drug discovery and innovation. Through this, the government provides support in terms of setting up world-class infrastructure, creating an internationally competitive scientific workforce for pharma R&D, and supporting venture funding for public and private research. Similarly, according to a report published by the US-China Economic and Security Review Commission, the Government of China invested USD 311 million and USD 420 million in stem cell research as a part of the 12th Five Year Plan (FYP) and the 13th FYP, respectively. In regard to follow-up implementation guidance published in 2017, Shanghai determined five areas as its developmental priorities, including bioproduct manufacturing, drug development & innovation, biotech industrialization, contract research activities, and global supply chain building. Considering these benefits, biopharmaceutical and pharmaceutical companies are increasingly focusing on drug discovery outsourcing to countries such as India and China, which is driving the adoption of cell culture media products in research applications.

Countries such as Brazil and Mexico are also expected to offer significant growth opportunities for players operating in the cell culture media market. The booming biopharmaceutical sector in these countries, increased risk of pandemics (such as swine flu and COVID-19), less-stringent regulatory guidelines, and the low manufacturing cost advantage are the major factors that are attracting market players to set up and expand their presence in these countries.

CHALLENGE:  Survival of small players and new entrants

The survival of small players and new entrants in the cell culture media market is a significant challenge. Established players such as Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group AG (Switzerland), Sartorius AG (Germany), and Danaher Corporation (US) account for a major share of the market. These players have a robust product portfolio and strong brand recognition. In addition, these key players tend to maintain their competitive advantage by acquiring new entrants or start-ups with an aim to boost their product portfolio. For instance, in July 2021, Sartorius AG acquired cell culture specialist Xell AG (Germany) with a focus on media for gene therapeutics and vaccines. This helped the company to expand its capabilities for manufacturing dry powder and liquid media.

Considering the strong presence of major players, it is difficult for small players and new entrants to compete in this market. Also, as large investments are required for the R&D and launch of innovative products, it is difficult for small players to sustain their operations and compete with established players that have large R&D budgets.

The serum-free media subsegment of the type segment dominated Cell Culture Media Market in 2020:

The cell culture media market, by type, is segmented into serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other cell culture media. In 2020, the serum-free media segment accounted for the largest share of the market. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth & productivity, better control over physiological responsiveness, and reduced risk of contamination by serum-borne adventitious agents in cell culture.

Cell Culture Media Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for Cell Culture Media Market in 2020.

The global cell culture media market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest share of the cell culture media market, followed by Europe. The growing regulatory approvals for cell culture-based vaccines, growth in the biotechnology & pharmaceutical industries, higher investments in cell-based research, and strong government support are the key factors driving the growth of the cell culture media market in North America..

Key Market Players

Key players in the Cell Culture Media Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD)

Segments covered

Type, Application, End user and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Companies covered

Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US), Caisson Laboratories Inc. (US), PromoCell GmbH (Germany), Cell Biologics, Inc. (US), InvivoGen (France), Pan-Biotech GmbH (Germany), Peprotech, Inc. (US), Cellular Technology Limited, LLC (US), ZenBio, Inc. (US), Athena Environmental Sciences, Inc. (US), Cyagen Biosciences (US), Biowest SAS (France), and Akron Biotech (US)

This report categorizes the cell culture media market into the following segments and subsegments:

Cell culture media Market, by Type

  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
  • Insect Cell Media
  • Serum-free Stem Cell Media
  • CAR T-cell Media
  • Other Serum-free Media
  • Classical Media & Salts
  • Stem Cell Culture Media
  • Specialty Media
  • Chemically defined Media
  • Other Cell Culture Media

Cell culture media Market, by Application

  • Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
  • Diagnostics
  • Drug Screening & Development
  • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
  • Other tissue engineering & regenerative medicine applications
  • Other Applications

Cell culture media Market, by End user

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Other End Users

Cell culture media Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East and Africa (MEA)

Recent Developments

  • In October 2021, Thermo Fisher Scientific Inc. (US) launched the Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which supports the large-scale growth and culture of functional natural killer (NK) cells with or without the use of feeder cells.
  • In July 2021, Sartorius AG acquired cell culture specialist Xell AG thus expanding its capabilities for manufacturing dry powder and liquid media.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 39)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 43)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MEDIA MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
          FIGURE 3 CELL CULTURE MEDIA MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
          FIGURE 6 CELL CULTURE MEDIA MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
          FIGURE 7 CELL CULTURE MEDIA MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS
           2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
    2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 54)
    FIGURE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 CELL CULTURE MEDIA MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MEDIA MARKET

4 PREMIUM INSIGHTS (Page No. - 58)
    4.1 CELL CULTURE MEDIA MARKET OVERVIEW
          FIGURE 13 RISING R&D SPENDING IN PHARMA COMPANIES AND EMERGING CELL CULTURE TECHNOLOGIES FOR CELL-BASED VACCINES WILL DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE AND COUNTRY (2020)
          FIGURE 14 SERUM-FREE MEDIA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN CELL CULTURE MEDIA MARKET IN 2020
    4.3 CELL CULTURE MEDIA MARKET SHARE, BY APPLICATION, 2021 VS. 2026
          FIGURE 15 BIOPHARMACEUTICAL PRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
    4.4 CELL CULTURE MEDIA MARKET, BY END USER, 2020 (USD MILLION)
          FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED THE MARKET IN 2020
    4.5 CELL CULTURE MEDIA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE CELL CULTURE MEDIA MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 62)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 18 CELL CULTURE MEDIA MARKET: DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGES
          TABLE 1 CELL CULTURE MEDIA MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising R&D spending in pharmaceutical companies
                                FIGURE 19 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
                    5.2.1.2 Emerging cell culture technologies for cell-based vaccines
                                TABLE 2 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
                    5.2.1.3 Increasing demand for monoclonal antibodies
                                TABLE 3 APPROVED MONOCLONAL ANTIBODIES BY US FDA FOR THERAPEUTIC USE
                    5.2.1.4 Growth in stem cell research
                    5.2.1.5 Launch of new cell culture media products by market players
                    5.2.1.6 Growing focus on personalized medicine
                                TABLE 4 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
                                FIGURE 20 GROWING NUMBER OF FDA APPROVALS FOR PERSONALIZED MEDICINES
           5.2.2 RESTRAINTS
                    5.2.2.1 Expensive cell biology research products
                    5.2.2.2 Ethical concerns regarding cell biology research
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Advancements in 3D cell culture
                    5.2.3.2 Increasing incidence of infectious diseases and outbreaks of pandemics
                    5.2.3.3 Emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Survival of small players and new entrants
    5.3 RANGES/SCENARIOS
          FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE CELL CULTURE MEDIA MARKET
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
          FIGURE 22 REVENUE SHIFT & NEW REVENUE POCKETS FOR CELL CULTURE MEDIA PROVIDERS
    5.5 IMPACT OF THE COVID-19 OUTBREAK ON THE CELL CULTURE MEDIA MARKET
          FIGURE 23 CELL CULTURE MEDIA MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019–2021
    5.6 PRICING ANALYSIS
          TABLE 5 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020)
    5.7 PATENT ANALYSIS
          FIGURE 24 PATENT APPLICATIONS FOR THE CELL CULTURE MEDIA MARKET, JANUARY 2011–FEBRUARY 2022
          TABLE 6 INDICATIVE LIST OF PATENTS IN THE CELL CULTURE MEDIA MARKET
    5.8 VALUE CHAIN ANALYSIS
          FIGURE 25 VALUE CHAIN ANALYSIS OF THE CELL CULTURE MEDIA MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
    5.9 SUPPLY CHAIN ANALYSIS
          FIGURE 26 CELL CULTURE MEDIA MARKET: SUPPLY CHAIN ANALYSIS
    5.10 ECOSYSTEM ANALYSIS OF THE CELL CULTURE MEDIA MARKET
           TABLE 7 SUPPLY CHAIN ECOSYSTEM
    5.11 PORTER’S FIVE FORCES ANALYSIS
           TABLE 8 CELL CULTURE MEDIA MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.11.1 THREAT OF NEW ENTRANTS
           5.11.2 THREAT OF SUBSTITUTES
           5.11.3 BARGAINING POWER OF SUPPLIERS
           5.11.4 BARGAINING POWER OF BUYERS
    5.12 REGULATORY ANALYSIS
           5.12.1 US
           5.12.2 EUROPE

6 CELL CULTURE MEDIA MARKET, BY TYPE (Page No. - 87)
    6.1 INTRODUCTION
          TABLE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
           6.1.1 SERUM-FREE MEDIA
                    TABLE 10 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
                    TABLE 11 SERUM-FREE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 12 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 13 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 14 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 15 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 16 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.1.1.1 CHO media
                               6.1.1.1.1 Growing adoption of CHO media in biopharmaceutical companies to drive the growth of this market segment
                                              TABLE 17 CHO MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 18 CHO MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 19 NORTH AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 20 EUROPE: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 21 ASIA PACIFIC: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 22 LATIN AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.1.1.2 HEK 293 media
                               6.1.1.2.1 Advantages of HEK 293 cell lines are expected to drive the growth of this market segment
                                              TABLE 23 HEK 293 MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 24 HEK 293 MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 25 NORTH AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                                              TABLE 26 EUROPE: HEK 293 MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 27 ASIA PACIFIC: HEK 293 MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 28 LATIN AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.1.1.3 BHK media
                               6.1.1.3.1 BHK media have wide applications in the production of recombinant proteins
                                              TABLE 29 BHK MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 30 BHK MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 31 NORTH AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 32 EUROPE: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 33 ASIA PACIFIC: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 34 LATIN AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.1.1.4 Vero cell media
                               6.1.1.4.1 Increasing role of Vero cells in research pertaining to viral vaccines to drive the growth of this market segment
                                              TABLE 35 VERO CELL MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 36 VERO CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 37 NORTH AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 38 EUROPE: VERO CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 39 ASIA PACIFIC: VERO CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 40 LATIN AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                    6.1.1.5 Serum-free stem cell media
                               6.1.1.5.1 Availability of funding for stem cell research driving the growth of this market segment
                                              TABLE 41 SERUM-FREE STEM CELL MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 42 SERUM-FREE STEM CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 43 NORTH AMERICA: SERUM-FREE STEM CELL MEDIA MARKET,  BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 44 EUROPE: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 45 ASIA PACIFIC: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 46 LATIN AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.1.1.6 Insect cell media
                               6.1.1.6.1 Growing adoption of insect cell media for heterologous protein expression driving the growth of this market segment
                                              TABLE 47 INSECT CELL MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 48 INSECT CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 49 NORTH AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 50 EUROPE: INSECT CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 51 ASIA PACIFIC: INSECT CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 52 LATIN AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                    6.1.1.7 CAR T-cell media
                               6.1.1.7.1 Growing demand for adoptive T-cell therapy to drive the growth of this market segment
                                              TABLE 53 CAR T-CELL MEDIA OFFERED BY KEY MARKET PLAYERS
                                              TABLE 54 CAR T-CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                              TABLE 55 NORTH AMERICA: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 56 EUROPE: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 57 ASIA PACIFIC: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                              TABLE 58 LATIN AMERICA: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.1.1.8 Other serum-free media
                                TABLE 59 OTHER SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
                                TABLE 60 OTHER SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 61 NORTH AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 62 EUROPE: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                                TABLE 63 ASIA PACIFIC: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 64 LATIN AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.1.2 CLASSICAL MEDIA & SALTS
                    6.1.2.1 Wide use of classical media & salts across all types of cell culture applications to drive the growth of this market segment
                                TABLE 65 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
                                TABLE 66 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 67 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 026 (USD MILLION)
                                TABLE 69 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 70 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.1.3 STEM CELL CULTURE MEDIA
                    6.1.3.1 Increasing collaborations between universities and pharma-biotech companies for stem cell research to drive the growth of this market segment
                                TABLE 71 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
                                TABLE 72 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 73 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 74 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 75 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                                TABLE 76 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.1.4 CHEMICALLY DEFINED (CD) MEDIA
                    6.1.4.1 Ability of CD media to increase reproducibility to drive the growth of this market segment
                                TABLE 77 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
                                TABLE 78 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 79 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 80 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 81 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
                                TABLE 82 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.1.5 SPECIALTY MEDIA
                    6.1.5.1 Ability of primary cells to proliferate in specialty media is expected to fuel the growth of this market segment
                                TABLE 83 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
                                TABLE 84 SPECIALTY MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 85 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 86 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 87 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 88 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.1.6 OTHER CELL CULTURE MEDIA
                    TABLE 89 OTHER CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
                    TABLE 90 OTHER CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 91 NORTH AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 92 EUROPE: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 94 LATIN AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 CELL CULTURE MEDIA MARKET, BY APPLICATION (Page No. - 127)
    7.1 INTRODUCTION
          TABLE 95 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    7.2 BIOPHARMACEUTICAL PRODUCTION
          TABLE 96 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
          TABLE 97 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 98 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 99 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 100 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 101 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2019–2026 (USD MILLION)
           7.2.1 MONOCLONAL ANTIBODY PRODUCTION
                    7.2.1.1 Growing demand for monoclonal antibody production is fueling the growth of this market segment
                                TABLE 102 INDICATIVE LIST OF APPROVED ANTIBODY PRODUCTS PRODUCED IN CHO CELLS
                                TABLE 103 INDICATIVE LIST OF MONOCLONAL ANTIBODIES WITH FDA AUTHORIZATION
                                TABLE 104 CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 105 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 106 EUROPE: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 107 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 108 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.2 VACCINE PRODUCTION
                    7.2.2.1 Growing government support for vaccine production to drive the growth of this market segment
                                TABLE 109 NIH FUNDING FOR VACCINE RESEARCH, 2018–2022 (USD MILLION)
                                TABLE 110 CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 111 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 112 EUROPE: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 113 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 114 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
                    TABLE 115 CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 116 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 117 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 118 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 119 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 DIAGNOSTICS
           7.3.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 120 CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 121 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 122 EUROPE: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 123 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 124 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 DRUG SCREENING & DEVELOPMENT
           7.4.1 ADOPTION OF CELL-BASED ASSAYS IN DRUG DISCOVERY WILL DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 125 CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 126 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 127 EUROPE: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 128 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 129 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
    7.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE
          TABLE 130 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 131 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION)
          TABLE 132 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 133 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 134 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 135 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
           7.5.1 CELL & GENE THERAPY
                    7.5.1.1 Increasing adoption of cell and gene therapies for treating patients to fuel the growth of this market
                                TABLE 136 CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY REGION, 2019–2026 (USD MILLION)
                                TABLE 137 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 138 EUROPE: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 139 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
                                TABLE 140 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
           7.5.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
                    TABLE 141 CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 142 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 143 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 144 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 145 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.6 OTHER APPLICATIONS
          TABLE 146 CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
          TABLE 147 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 148 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 149 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 150 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

8 CELL CULTURE MEDIA MARKET, BY END USER (Page No. - 157)
    8.1 INTRODUCTION
          TABLE 151 CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           8.2.1 INCREASING RESEARCH EXPENDITURE BY PHARMA AND BIOTECH COMPANIES WILL DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 152 CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 153 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 154 EUROPE: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 155 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 156 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
           8.3.1 INCREASING APPLICATIONS OF CELL CULTURE MEDIA IN DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 157 CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 158 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 159 EUROPE: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 160 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 161 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 RESEARCH & ACADEMIC INSTITUTES
           8.4.1 GROWING PREVALENCE OF CANCER AND INCREASING RESEARCH FUNDING TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 162 CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 163 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 164 EUROPE: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 165 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 166 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.5 OTHER END USERS
          TABLE 167 CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
          TABLE 168 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 169 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER END USERS,  BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 170 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 171 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 CELL CULTURE MEDIA MARKET, BY REGION (Page No. - 170)
    9.1 INTRODUCTION
          TABLE 172 CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
          FIGURE 27 NORTH AMERICA: CELL CULTURE MEDIA MARKET SNAPSHOT
          TABLE 173 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 174 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 175 NORTH AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 176 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 177 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 178 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 179 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Growing pharmaceutical and biotechnology sector in the US to drive market growth
                                TABLE 180 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 181 US: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 182 US: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 183 US: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 184 US: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 185 US: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Increase in stem cell research funding in Canada to fuel market growth
                                TABLE 186 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 187 CANADA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 188 CANADA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 189 CANADA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 190 CANADA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 191 CANADA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.3 EUROPE
          TABLE 192 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
          TABLE 193 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 194 EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
          TABLE 195 EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
          TABLE 196 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 197 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 198 EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Strong growth in the biotechnology industry in Germany to drive market growth
                                TABLE 199 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 200 GERMANY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 201 GERMANY: CELL CULTURE MEDIA MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
                                TABLE 202 GERMANY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 203 GERMANY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 204 GERMANY: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Advancements in the life sciences sector to boost market growth in the UK
                                TABLE 205 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 206 UK: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
                                TABLE 207 UK: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 208 UK: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 209 UK: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 210 UK: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Increase in government funding for life science research to drive market growth in France
                                TABLE 211 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 212 FRANCE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 213 FRANCE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 214 FRANCE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 215 FRANCE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 216 FRANCE: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Growing support for life science research in Italy to fuel market growth
                                TABLE 217 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 218 ITALY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 219 ITALY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 220 ITALY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 221 ITALY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 222 ITALY: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Advancement of translational personalized medicine to aid market growth in Spain
                                TABLE 223 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 224 SPAIN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 225 SPAIN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 226 SPAIN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 227 SPAIN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 228 SPAIN: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 229 ROE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 230 ROE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 231 ROE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 232 ROE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 233 ROE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 234 ROE: CELL CULTURE MEDIA MARKET, BY END USER 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 28 ASIA PACIFIC: CELL CULTURE MEDIA MARKET SNAPSHOT
          TABLE 235 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 236 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 237 ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 238 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 239 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 240 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 241 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 China to register the highest growth rate in the Asia Pacific cell culture media market during the forecast period
                                TABLE 242 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 243 CHINA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 244 CHINA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 245 CHINA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 246 CHINA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 247 CHINA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Increasing geriatric population along with rising cancer cases to drive market growth in Japan
                                TABLE 248 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 249 JAPAN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 250 JAPAN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 251 JAPAN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 252 JAPAN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 253 JAPAN: CELL CULTURE MEDIA MARKET, BY END USER,  2019–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Government support for scientific research and expansion of the pharma-biotech sector to drive market growth in India
                                TABLE 254 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 255 INDIA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 256 INDIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 257 INDIA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 258 INDIA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 259 INDIA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 260 ROAPAC: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 261 ROAPAC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 262 ROAPAC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 263 ROAPAC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 264 ROAPAC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 265 ROAPAC: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
          TABLE 266 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 267 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 268 LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 269 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 270 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 271 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 272 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Expanding pharmaceutical market in Brazil to fuel market growth
                                TABLE 273 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
                                TABLE 274 BRAZIL: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
                                TABLE 275 BRAZIL: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 276 BRAZIL: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 277 BRAZIL: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 278 BRAZIL: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Growth in pharmaceutical R&D and manufacturing to drive the demand for cell culture media in Mexico
                                TABLE 279 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 280 MEXICO: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 281 MEXICO: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                TABLE 282 MEXICO: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 283 MEXICO: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 284 MEXICO: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 285 ROLATAM: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 286 ROLATAM: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 287 ROLATAM: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 288 ROLATAM: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 289 ROLATAM: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 290 ROLATAM: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS DRIVING MARKET GROWTH IN MEA
                    TABLE 291 MEA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 292 MEA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    TABLE 293 MEA: CELL CULTURE MEDIA MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
                    TABLE 294 MEA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 295 MEA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 296 MEA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 234)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 29 KEY DEVELOPMENTS IN THE CELL CULTURE MEDIA MARKET, 2019–2022
     10.3 MARKET SHARE ANALYSIS
             FIGURE 30 CELL CULTURE MEDIA MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
             TABLE 297 CELL CULTURE MEDIA MARKET: DEGREE OF COMPETITION
     10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
             FIGURE 31 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE CELL CULTURE MEDIA MARKET, 2018–2020
     10.5 COMPANY EVALUATION QUADRANT
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 32 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT, 2020
     10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 33 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
     10.7 PRODUCT FOOTPRINT OF COMPANIES
             TABLE 298 PRODUCT PORTFOLIO ANALYSIS: CELL CULTURE MEDIA MARKET (2020)
     10.8 REGIONAL FOOTPRINT OF COMPANIES
             TABLE 299 REGIONAL FOOTPRINT OF COMPANIES: CELL CULTURE MEDIA MARKET (2020)
     10.9 COMPETITIVE SCENARIO
             TABLE 300 PRODUCT LAUNCHES
             TABLE 301 DEALS
             TABLE 302 EXPANSIONS

11 COMPANY PROFILES (Page No. - 247)
     11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 303 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
             11.1.2 MERCK KGAA
                        TABLE 304 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020)
             11.1.3 DANAHER CORPORATION
                        TABLE 305 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.4 SARTORIUS AG
                        TABLE 306 SARTORIUS AG: BUSINESS OVERVIEW
                        FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2020)
             11.1.5 CORNING INCORPORATED
                        TABLE 307 CORNING INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 38 CORNING INCORPORATED: COMPANY SNAPSHOT (2020)
             11.1.6 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION)
                        TABLE 308 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.7 LONZA GROUP AG
                        TABLE 309 LONZA GROUP AG: BUSINESS OVERVIEW
                        FIGURE 40 LONZA GROUP AG: COMPANY SNAPSHOT (2020)
             11.1.8 BECTON, DICKINSON AND COMPANY (BD)
                        TABLE 310 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 41 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
             11.1.9 MILTENYI BIOTEC
                        TABLE 311 MILTENYI BIOTEC: BUSINESS OVERVIEW
             11.1.10 HIMEDIA LABORATORIES PVT. LTD.
                        TABLE 312 HIMEDIA LABORATORIES PVT. LTD.: BUSINESS OVERVIEW
             11.1.11 STEMCELL TECHNOLOGIES INC.
                        TABLE 313 STEMCELL TECHNOLOGIES INC.: BUSINESS OVERVIEW
             11.1.12 BIOLOGOS LLC.
                        TABLE 314 BIOLOGOS LLC.: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS
             11.2.1 CELL APPLICATIONS, INC.
             11.2.2 CAISSON LABORATORIES INC.
             11.2.3 PROMOCELL GMBH
             11.2.4 CELL BIOLOGICS, INC.
             11.2.5 INVIVOGEN
             11.2.6 PAN-BIOTECH GMBH
             11.2.7 PEPROTECH, INC.
             11.2.8 CELLULAR TECHNOLOGY LIMITED LLC.
             11.2.9 ZEN-BIO, INC.
             11.2.10 ATHENA ENVIRONMENTAL SCIENCES, INC.
             11.2.11 CYAGEN BIOSCIENCES
             11.2.12 BIOWEST SAS
             11.2.13 AKRON BIOTECH

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 297)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell culture media market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as the World Health Organization (WHO), American Society for Cell Biology (ASCB), American Society for Gene and Cell Therapy (ASGCT), International Serum Industry Association (ISIA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), Pharmaceutical Research and Manufacturers of America (PhRMA), Department of Biotechnology (DBT), French National Research Agency, Ministry of Education, University and Research (MIUR), National Institute of Statistics (INE), Japan Agency for Medical Research and Development, Department of Regenerative Medicine and Cell and Gene Therapies, Ministry of Health and Welfare (MoHW). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global cell culture media market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global cell culture media market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Cell Culture Media Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the cell culture media market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the cell culture media market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the cell culture media business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Objectives

  • To define, describe, and forecast the global cell culture media market based on type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall cell culture media market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions; new product launches; expansions; and agreements, partnerships, and collaborations in the cell culture media market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Cell Culture Media Market Size,  Share & Growth Report
Report Code
BT 8052
Published ON
Mar, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status